| Development of Health-related Quality of Life Instrument for Patients With Cystinosis (NCT05959668) | Cystinose Stiftung | 2022-05-01 |
| Genetic Newborn Screening for Cystinosis and Primary Hyperoxaluria (NCT05843851) | Cystinose Stiftung | 2022-03-15 |
| Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2) (NCT04125927) | RECORDATI GROUP | 2020-09-01 |
| A Phase 2 Study of ELX-02 in Patients With Nephropathic Cystinosis (NCT04069260) | Eloxx Pharmaceuticals, Inc. | 2019-08-02 |
| Stem Cell Gene Therapy for Cystinosis (NCT03897361) | University of California, San Diego | 2019-07-08 |
| Early Check: Expanded Screening in Newborns (NCT03655223) | RTI International | 2018-10-15 |
| Genetic Newborn Screening for Cystinosis and Spinal Muscular Atrophy (NCT06027385) | Cystinose Stiftung | 2018-01-15 |
| European Cystinosis Cohort (NCT05901077) | Institut National de la Santé Et de la Recherche Médicale, France | 2017-04-20 |
| The Functional Consequences of the CTNS-deletion for the TRPV1-receptor in Cystinosis Patients (NCT02533076) | Universitaire Ziekenhuizen KU Leuven | 2014-11-01 |
| Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis (NCT02124070) | National Human Genome Research Institute (NHGRI) | 2014-03-26 |
| Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) in Cystinosis (NCT01733316) | Amgen | 2013-01-31 |
| A Cohort of Patients With Cystinosis : Compliance to Cysteamine and Neurological Complications (NCT02012114) | Hospices Civils de Lyon | 2011-12-01 |
| Study in Healthy Adults to Determine the Effect That Food Has on the Absorption and Delivery of the Drug Cystagon™ (NCT01432561) | University of California, San Diego | 2011-09-01 |
| N Acetyl Cysteine for Cystinosis Patients (NCT01614431) | University of Sao Paulo | 2011-03-01 |
| Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) (NCT01197378) | Amgen | 2010-08-27 |
| Cure Cystinosis International Registry (NCT01327807) | Cystinosis Research Foundation | 2010-08-01 |
| Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (NCT01793168) | Sanford Health | 2010-07-01 |
| Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis (NCT01000961) | Amgen | 2010-06-01 |
| National Registry of Rare Kidney Diseases (NCT06065852) | UK Kidney Association | 2009-11-06 |
| Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With Cystinosis (NCT00872729) | Amgen | 2009-05-01 |
| Clinical and Biological Study of Sub-pigmentation During Infantile Cystinosis (NCT00822250) | Centre Hospitalier Universitaire de Nice | 2008-04-01 |
| Kidney Transplantation in Patients With Cystinosis (NCT00074516) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-12-10 |
| The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control Study (NCT00071903) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2003-10-30 |
| Evaluation of Fanconi Syndrome and Cystinosis (NCT00004350) | National Center for Research Resources (NCRR) | 1999-10-01 |
| Establishment of a Database for Long-Term Monitoring of Patients With Nephropathic Cystinosis (NCT00004312) | National Center for Research Resources (NCRR) | 1999-10-01 |
| New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis (NCT00001736) | National Eye Institute (NEI) | 1998-05-01 |
| Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis (NCT00001213) | National Eye Institute (NEI) | 1986-04-01 |
| Use of Cysteamine in the Treatment of Cystinosis (NCT00359684) | National Human Genome Research Institute (NHGRI) | 1979-01-04 |